Get confidential information on HIV/AIDS, Chlamydia, Gonorrhea, Syphilis, HPV, Genital HPV, Genital HPV infection, Genital Herpes, Bacterial Vaginosis, PID, Trichomoniasis, and other STDs. Being tested is the ONLY way to know for sure if you are infected with HIV. (Also see: State of Florida)
I AM A HUMAN AND NOT A ROBOT
⇧ Checking the box is REQUIRED for validation.
GEORGIA: AIDS Walk’s Diverse Crowd to Raise $900,000 to Fight HIV
Fri, 30 Sep 2011 – http://www.thegavoice.com
AIDS Walk Atlanta, which raises funds for AID Atlanta and nine other local AIDS service organizations, is set for Sunday, Oct. 16, in Piedmont Park. “We are trying to attract 7,500 walkers, 500 runners and $950,000,” said Tracy Elliott, executive director of AID Atlanta. The walk continues to build back to its 2007, pre-recession peak of $1.1 million, he said. Check-in begins at 11:30 a.m.; the 5K run starts at 1 p.m.; and the walk steps off at 2 p.m. For more information, telephone 404-876-9255 or visit http://www.aidswalkatlanta.com.
UNITED KINGDOM: Circumcision Among Men Who Have Sex with Men in London, United Kingdom: An Unlikely Strategy for HIV Prevention
Sat, 01 Oct 2011 – http://www.stdjournal.com
Male circumcision is unlikely to be a workable HIV prevention strategy among London MSM, the current study suggests. The team undertook the research to explore attitudes about circumcision among MSM in London and to assess the feasibility of conducting research on circumcision and HIV prevention among these men. In May and June 2008, a convenience sample of MSM visiting gyms in central London completed a confidential, self-administered questionnaire. The information collected included demographic characteristics, self-reported HIV status, sexual behavior, circumcision status, attitudes about circumcision, and willingness to take part in research on circumcision and HIV prevention. Among the 653 participants, 29 percent reported they were circumcised. HIV prevalence among the MSM was 23.3 percent and did not differ significantly between circumcised (18.6 percent) and uncircumcised (25.2 percent) men (adjusted odds ratio=0.79; 95 percent confidence interval: 0.50-1.26). The proportion of participants reporting unprotected anal intercourse in the past three months was similar in the circumcised (38.8 percent) and uncircumcised (36.7 percent) groups (AOR=1.06; 95 percent CI: 0.72-1.55). The uncircumcised MSM were less likely to think there were benefits to being circumcised compared to the circumcised men (31.2 percent vs. 65.4 percent, P<0.001). Just 10.3 percent of the uncircumcised men indicated a willingness to take part in research on circumcision as a strategy to prevent HIV transmission. “Most uncircumcised MSM in this London survey were unwilling to participate in research on circumcision and HIV prevention,” the authors concluded. “Only a minority of uncircumcised men thought that there were benefits of circumcision. It is unlikely that circumcision would be a feasible strategy for HIV prevention among MSM in London.”
TENNESSEE: Politics Obscures HPV Vaccine’s Benefits
Sun, 09 Oct 2011 – http://www.tennessean.com
Tennessee has a cervical cancer mortality rate of 2.8 deaths per 100,000 women, compared with the national average rate of 2.4, according to CDC data for 2007. However, only 33 percent of Tennessee females ages 13-17 had received at least one dose of vaccine against human papillomavirus in 2010, CDC reported in August. About one-quarter of girls had received the full three doses, compared with a national average of about one in three. “It is recommended by the CDC and the American Academy of Pediatrics,” Dr. Thomas Frieden, CDC’s director, said of the HPV vaccine. “It has been reviewed by the Institute of Medicine. Because it protects against a disease that is sexually transmitted, it gets fairly controversial.” “Our biggest challenge is trying to overcome all the misinformation that is out there,” said Dr. Kelly Moore, medical director of immunizations for the Tennessee Department of Health. “The bottom line is this is an exciting advance in preventing cancer in future generations.” “We give it at [ages] 11 and 12 for very practical reasons,” said Moore. “It’s not because we are trying to force people to have conversations about sexual activity with preteens. It’s because that’s when we are giving other vaccines.” The three-dose regimen can cost $400-$450, but health departments provide the vaccinations free to males and females 19 or younger. “More and more evidence is becoming available showing that cancers are caused by HPV in men also,” Moore said, though she noted Tennessee has no plans to mandate the shots.